Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: Combined mTOR and AKT inhibitor therapy

William S. Holland, Clifford G Tepper, Jose E. Pietri, Danielle C. Chinn, David R Gandara, Philip Mack, Primo N Lara

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: Combined mTOR and AKT inhibitor therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds